Filter Results
:
(38)
Show Results For
-
All HBS Web
(396)
- Faculty Publications (38)
Show Results For
-
All HBS Web
(396)
- Faculty Publications (38)
Vaccine
→
Page 1 of
38
Results
→
Are you looking for?
Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...
Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...
- Article
America's Pharmacies Can Do a Lot More Vaccinations
By: Scott Duke Kominers and Alex Tabarrok
Kominers, Scott Duke, and Alex Tabarrok. "America's Pharmacies Can Do a Lot More Vaccinations." Bloomberg Opinion (February 17, 2021).
- February 2021
- Supplement
The Coronavirus (COVID-19) Pandemic and the Global Economy (B)
By: Alberto Cavallo and Christian Godwin
By December 2020, the COVID-19 pandemic had swept across the globe, creating widespread disruption in all aspects of everyday life. Almost 90 million people had been infected and nearly two million had died from the disease. By this point in the pandemic—a year since...
View Details
Keywords:
Economy
- January 28, 2021
- Other Article
Lessons from the U.S.'s Rocky Vaccine Rollout
By: Robert S. Huckman and Bradley R. Staats
The rocky rollout of the COVID-19 vaccines is emblematic of many of the problems with the U.S. health care system. The United States is blessed with highly trained, excellent, and compassionate care providers and terrific research and development that has led to novel...
View Details
Keywords:
Health Care;
Covid-19;
Vaccines;
Operations Improvement;
Health Pandemics;
Health Care And Treatment;
Service Delivery;
Operations;
Performance Improvement;
Health;
Health Industry;
United States
Huckman, Robert S., and Bradley R. Staats. "Lessons from the U.S.'s Rocky Vaccine Rollout." Harvard Business Review Digital Articles (January 28, 2021).
- January 2021
- Case
Serum Institute of India (SII) : Racing to Save Lives During a Pandemic
By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how...
View Details
- December 2020 (Revised February 2021)
- Case
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)
By: Linda A. Hill and Emily Tedards
In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone three large-scale mergers and acquisitions. As Ku and his new leadership team set out to build a proactive, end-to-end, digital and physical clinical...
View Details
Keywords:
Digital Technology;
Customer-centricity;
Innovation;
Customer Focus;
Talent;
Talent Management;
Leadership;
Innovation And Invention;
Transformation;
Organizational Culture;
Customer Focus And Relationships;
Change Management;
Talent And Talent Management;
Supply Chain;
Mission And Purpose
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)." Harvard Business School Case 421-037, December 2020. (Revised February 2021.)
- Article
The Case for a COVID Vaccine Lottery
By: Scott Duke Kominers and Alex Tabarrok
Even the smartest distribution plans are complicated by a stubborn fact: We won't have enough for everyone right away.
View Details
Kominers, Scott Duke, and Alex Tabarrok. "The Case for a COVID Vaccine Lottery." Bloomberg Opinion (November 9, 2020).
- October 2020
- Teaching Plan
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,...
View Details
- September 2020
- Case
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,...
View Details
Keywords:
Vaccines;
Health Pandemics;
Health Testing And Trials;
Innovation And Management;
Innovation Strategy;
Technological Innovation;
Business Strategy;
Pharmaceutical Industry
Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
- September 2020 (Revised October 2020)
- Case
Moderna (A)
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital...
View Details
Keywords:
Covid-19;
vaccine;
Digital Organizations;
Organizational Structure;
Operations;
Management;
Health Pandemics;
Research And Development;
Goals And Objectives
Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised October 2020.)
- Article
Vaccines Use Bizarre Stuff. We Need a Supply Chain Now.
By: Scott Duke Kominers and Alex Tabarrok
Kominers, Scott Duke, and Alex Tabarrok. "Vaccines Use Bizarre Stuff. We Need a Supply Chain Now." Bloomberg Opinion (August 18, 2020).
- Article
Sustainability, Business, and Health
By: George Serafeim, Amanda M. Rischbieth and Howard K. Koh
The coronavirus disease 2019 (COVID-19) pandemic has demonstrated that response demands involvement from every sector of society. As a major example, some businesses have stepped up in ways previously unimaginable. Garment companies have repurposed production to face...
View Details
Keywords:
Covid;
Covid-19;
Sustainability;
Health And Wellness;
Corporate Social Responsibility;
Health Pandemics;
Health;
Corporate Social Responsibility And Impact;
Corporate Accountability;
Health Care And Treatment
Serafeim, George, Amanda M. Rischbieth, and Howard K. Koh. "Sustainability, Business, and Health." JAMA, the Journal of the American Medical Association 324, no. 2 (July 14, 2020): 147–148.
- June 2020
- Article
Overcoming Barriers to Early Disease Intervention
By: H. Hugo Caicedo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland and Gary P. Pisano
It is widely acknowledged that earlier intervention in many disease processes leads to better patient outcomes and lower treatment costs. To date, most efforts at early disease intervention have focused on "primary prevention" which focuses on preventing diseases in...
View Details
Caicedo, H. Hugo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland, and Gary P. Pisano. "Overcoming Barriers to Early Disease Intervention." Nature Biotechnology 38, no. 6 (June 2020).
- May 2020
- Case
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (A)
By: Linda A. Hill, Allison J. Wigen and Emily Tedards
Michael Ku joined Pfizer in 2011, after the company had undergone three large-scale mergers and acquisitions. His mission was to drive the digital transformation of the company’s clinical supply chain, but he knew he had to start with the culture. Over the next eight...
View Details
Keywords:
Innovation;
Digital;
Change;
Culture;
Management;
Talent;
Supply Chain;
Pharmaceutical Companies;
Customer-centricity;
Collaboration;
Cross-functional Management;
Purpose;
Leadership;
Innovation And Invention;
Transformation;
Organizational Culture;
Change Management;
Talent And Talent Management;
Customer Focus And Relationships;
Supply Chain;
Decision Making;
Mission And Purpose
Hill, Linda A., Allison J. Wigen, and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (A)." Harvard Business School Case 420-108, May 2020.
- March 13, 2020
- Editorial
Scale the Price for a Coronavirus Vaccine by the Harm it Averts
By: Amitabh Chandra
Chandra, Amitabh. "Scale the Price for a Coronavirus Vaccine by the Harm it Averts." Boston Globe (March 13, 2020).
- May 6, 2020
- Article
We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic
By: Gary P. Pisano
The ultimate solutions to the Covid-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already...
View Details
Pisano, Gary P. "We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic." Harvard Business Review Digital Articles (May 6, 2020).
- May 2020
- Case
Gavi and COVID-19: Pandemic of the Century
By: Tarun Khanna and Sid Misra
Gavi has helped immunize over 760 million children in the world's poorest countries over the past 20 years saving 13 million lives. How should Gavi respond to the need for a vaccine for the worldwide COVID-19 pandemic?
View Details
Keywords:
vaccine;
Pandemics;
Healthcare;
Covid-19;
Health Pandemics;
Health Care And Treatment;
Emerging Markets;
Crisis Management;
Alliances
Khanna, Tarun, and Sid Misra. "Gavi and COVID-19: Pandemic of the Century." Harvard Business School Case 720-451, May 2020.
- Article
Believe in Vaccine Bets Like Bill Gates's
Commitment of public or private funds upfront speeds development, production, and distribution.
View Details
Keywords:
Coronavirus;
vaccine;
Financing;
Health Pandemics;
Health Care And Treatment;
Product Development;
Production;
Distribution
Kominers, Scott Duke. "Believe in Vaccine Bets Like Bill Gates's." Bloomberg Opinion (April 28, 2020).
- December 2019
- Case
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem (Abridged)
By: Willy Shih
This case describes the efforts of the Bill & Melinda Gates Foundation to lower the cost of producing vaccines to prevent polio infections. It is an abridged version of HBS Case No. 620-021 with less emphasis on comparison between traditional and the new compact...
View Details
Keywords:
vaccine;
Manufacturing;
Barriers To Entry;
Production;
Cost;
Technological Innovation;
Market Entry And Exit;
Pharmaceutical Industry
Shih, Willy. "Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem (Abridged)." Harvard Business School Case 620-071, December 2019.
- September 2019
- Case
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem
By: Willy C. Shih
Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine...
View Details
Keywords:
vaccine;
Production;
Supply Chain;
Product;
Biotechnology Industry;
Pharmaceutical Industry;
Manufacturing Industry;
Belgium
Shih, Willy C. "Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem." Harvard Business School Case 620-021, September 2019.
- 2020
- Working Paper
HIV Tests and AIDS Treatments: Case Histories of Significant Medical Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
We describe how a diverse cast of characters including public health organizations, research laboratories, for-profit health care companies, activists and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case history shows, a...
View Details
Keywords:
Health Care And Treatment;
Technological Innovation;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation And Invention;
Innovation And Invention;
Governing Rules, Regulations, And Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments: Case Histories of Significant Medical Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised July 2020.)
Are you looking for?
Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...
Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of...